Skip to content
MarketScale
‹ Back to IndustriesHealthcare

NASA and the Partnership With Bone Marrow Research

In the 70’s. NASA was doing more than sending missions to the moon and to other planets in the solar system; they were also involved in advancing medical research—specifically, freezing bone marrow. In order to maintain healthy bone marrow for transplant, cells have to be chilled to temperatures that traditional freezers couldn’t maintain. This temperature…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

In the 70’s. NASA was doing more than sending missions to the moon and to other planets in the solar system; they were also involved in advancing medical research—specifically, freezing bone marrow. In order to maintain healthy bone marrow for transplant, cells have to be chilled to temperatures that traditional freezers couldn’t maintain. This temperature limitation also created another complication: when cooling samples too quickly, the water expands, bursting the cell wall. When cooling too slowly, the cell dies.

Tom Williams, an engineer working on NASA’s communications, was involved in the project. He spent a few years developing a liquid nitrogen freezer that chilled marrow without destroying the sample. He used a compound that modified the way water froze within the cell and identified a cooling rate and process that avoided cell death. NASA patented the tech in the late 70s, which made licensing to the medical community possible.

People think NASA just launches rockets, but we’re doing core research,” says Williams. “Many medical products use technologies derived from those developed right here at Goddard [in Greenbelt, Maryland].”

To read the full article from PHYS.ORG, click here.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

UpDoc has received FDA clearance for its LLM-driven diabetes management app, while Aidoc has been granted breakthrough device status for its AI-drafted radiology reports. This marks a significant milestone as clinical AI applications continue to gain regulatory approval and recognition. The advancements showcase the potential of AI in improving healthcare management and diagnostic processes.

  • 01UpDoc's diabetes management app receives FDA clearance.
  • 02Aidoc achieves breakthrough device status for AI radiology reports.
  • 03Regulatory milestones highlight AI's growing role in healthcare.

Jul 13, 2026

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

The chief data and AI officer at Cedars-Sinai discusses the evolving role of AI in healthcare. While the first wave of AI focused on enhancing productivity, the second wave is expected to transform job roles and the workforce structure. This shift indicates a deeper integration of AI technology in healthcare operations.

  • 01First wave of AI increased productivity in healthcare.
  • 02Second wave aims to restructure job roles.
  • 03AI will deeply integrate into healthcare operations.

Jul 13, 2026

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation in US manufacturing lags, with 80% of factories lacking automation tools. In contrast, medtech manufacturers are advancing with technologies like micro-molding and ultrasonic welding. This disparity highlights a growing gap in technology adoption across different sectors.

  • 0180% of US factories have no automation.
  • 02Medtech manufacturers are investing in automation technologies.
  • 03There's an increasing divide in technology adoption across industries.

Jul 12, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512